PRGO
Price
$14.26
Change
+$0.24 (+1.71%)
Updated
Oct 2 closing price
Capitalization
2.1B
37 days until earnings call
Intraday BUY SELL Signals
TAK
Price
$17.86
Change
-$0.00 (-0.00%)
Updated
Oct 2 closing price
Capitalization
60.13B
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRGO vs TAK

PRGO vs TAK Comparison Chart in %
View a ticker or compare two or three
VS
PRGO vs. TAK commentary
Oct 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGO is a Hold and TAK is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PRGO vs TAK: Fundamental Ratings
PRGO
TAK
OUTLOOK RATING
1..100
8571
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10055
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
4248
P/E GROWTH RATING
1..100
282
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (3) in the Pharmaceuticals Major industry is somewhat better than the same rating for PRGO (54) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than PRGO’s over the last 12 months.

TAK's Profit vs Risk Rating (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for PRGO (100) in the Pharmaceuticals Other industry. This means that TAK’s stock grew somewhat faster than PRGO’s over the last 12 months.

TAK's SMR Rating (90) in the Pharmaceuticals Major industry is in the same range as PRGO (98) in the Pharmaceuticals Other industry. This means that TAK’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's Price Growth Rating (42) in the Pharmaceuticals Other industry is in the same range as TAK (48) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to TAK’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for TAK (82) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew significantly faster than TAK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRGOTAK
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
43%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
44%
Momentum
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
52%
MACD
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 11 days ago
63%
Bullish Trend 8 days ago
49%
Declines
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 5 days ago
44%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
48%
Aroon
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
51%
COMPARISON
Comparison
Oct 05, 2026
Stock price -- (PRGO: $14.26 vs. TAK: $17.86)
Brand notoriety: PRGO and TAK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRGO: 76% vs. TAK: 78%
Market capitalization -- PRGO: $2.1B vs. TAK: $60.13B
PRGO [@Pharmaceuticals: Generic] is valued at $2.1B. TAK’s [@Pharmaceuticals: Generic] market capitalization is $60.13B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRGO’s FA Score shows that 1 FA rating(s) are green while TAK’s FA Score has 1 green FA rating(s).

  • PRGO’s FA Score: 1 green, 4 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRGO and TAK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRGO’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 4 bullish TA indicator(s).

  • PRGO’s TA Score: 4 bullish, 5 bearish.
  • TAK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TAK is a better buy in the short-term than PRGO.

Price Growth

PRGO (@Pharmaceuticals: Generic) experienced а -7.52% price change this week, while TAK (@Pharmaceuticals: Generic) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.61%. For the same industry, the average monthly price growth was -8.00%, and the average quarterly price growth was +30.03%.

Reported Earning Dates

PRGO is expected to report earnings on Nov 11, 2026.

TAK is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
PRGO
Daily Signal:
Gain/Loss:
TAK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUMA0.520.02
+3.70%
Humacyte
GNW9.550.24
+2.58%
Genworth Financial
GH177.803.05
+1.75%
Guardant Health
FISI39.980.50
+1.27%
Financial Institutions
RAIN0.77-0.06
-7.70%
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO INC

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+1.71%
SUPN - PRGO
49%
Loosely correlated
+0.47%
ELAN - PRGO
37%
Loosely correlated
+1.70%
EVO - PRGO
35%
Loosely correlated
-2.74%
PBH - PRGO
35%
Loosely correlated
+1.09%
ALVO - PRGO
34%
Loosely correlated
-3.02%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
N/A
HLN - TAK
44%
Loosely correlated
+0.92%
COLL - TAK
29%
Poorly correlated
+0.82%
PBH - TAK
28%
Poorly correlated
+1.09%
ANIK - TAK
28%
Poorly correlated
-1.34%
PRGO - TAK
27%
Poorly correlated
+1.71%
More